Safety and efficacy of indocyanine green fluorescence imaging for real-time guidance of laparoscopic thermal ablation in patients with liver cancer

References

• Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. doi:10.1038/s41572-020-00240-3.
   PubMed Web of Science ®Google Scholar
• Li X, Ramadori P, Pfister D, et al. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat Rev Cancer. 2021;21(9):541–557. doi:10.1038/s41568-021-00383-9.
   PubMed Web of Science ®Google Scholar
• Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12(8):895–904. doi:10.1038/nm1469.
   PubMed Web of Science ®Google Scholar
• Milette S, Sicklick JK, Lowy AM, et al. Molecular pathways: targeting the microenvironment of liver metastases. Clin Cancer Res. 2017;23(21):6390–6399. doi:10.1158/1078-0432.CCR-15-1636.
   PubMed Web of Science ®Google Scholar
• De Toni EN, Schlesinger-Raab A, Fuchs M, et al. Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study. Gut. 2020;69(1):168–176. doi:10.1136/gutjnl-2018-318193.
   PubMed Web of Science ®Google Scholar
• Llovet JM, De Baere T, Kulik L, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18(5):293–313. doi:10.1038/s41575-020-00395-0.
   PubMed Web of Science ®Google Scholar
• Shin SW, Ahn KS, Kim SW, et al. Liver resection versus local ablation therapies for hepatocellular carcinoma within the milan criteria: a systematic review and meta-analysis. Ann Surg. 2021;273(4):656–666. doi:10.1097/SLA.0000000000004350.
   PubMed Web of Science ®Google Scholar
• Lam VW, Ng KK, Chok KS, et al. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors. Ann Surg Oncol. 2008;15(3):782–790. doi:10.1245/s10434-007-9733-9.
   PubMed Web of Science ®Google Scholar
• Teratani T, Yoshida H, Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology. 2006;43(5):1101–1108. doi:10.1002/hep.21164.
   PubMed Web of Science ®Google Scholar
• Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol. 2003;14(10):1267–1274. doi:10.1097/01.rvi.0000092666.72261.6b.
   PubMed Web of Science ®Google Scholar
• Zorbas G, Samaras T. A study of the sink effect by blood vessels in radiofrequency ablation. Comput Biol Med. 2015;57:182–186. doi:10.1016/j.compbiomed.2014.12.014.
   PubMed Web of Science ®Google Scholar
• Kim JW, Shin SS, Heo SH, et al. Ultrasound-Guided percutaneous radiofrequency ablation of liver tumors: how We do it safely and completely. Korean J Radiol. 2015;16(6):1226–1239. doi:10.3348/kjr.2015.16.6.1226.
   PubMed Web of Science ®Google Scholar
• Lee S, Kang TW, Song KD, et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. 2021;273(3):564–571. doi:10.1097/SLA.0000000000003268.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Zeng Y, Xu Y, et al. Ultrasound molecular imaging as a potential non-invasive diagnosis to detect the margin of hepatocarcinoma via CSF-1R targeting. Front Bioeng Biotechnol. 2020;8:783. doi:10.3389/fbioe.2020.00783.
   PubMed Web of Science ®Google Scholar
• Lauwerends LJ, van Driel P, Baatenburg de Jong RJ, et al. Real-time fluorescence imaging in intraoperative decision making for cancer surgery. Lancet Oncol. 2021;22(5):e186–e195. doi:10.1016/S1470-2045(20)30600-8.
   PubMed Web of Science ®Google Scholar
• Fan Z, Zong J, Lau WY, et al. Indocyanine green and its nanosynthetic particles for the diagnosis and treatment of hepatocellular carcinoma. Am J Transl Res. 2020;12(6):2344–2352.
   PubMed Web of Science ®Google Scholar
• Ishizawa T, Fukushima N, Shibahara J, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer. 2009;115(11):2491–2504. doi:10.1002/cncr.24291.
   PubMed Web of Science ®Google Scholar
• Aoki T, Yasuda D, Shimizu Y, et al. Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection. World J Surg. 2008;32(8):1763–1767. doi:10.1007/s00268-008-9620-y.
   PubMed Web of Science ®Google Scholar
• Ishizawa T, Zuker NB, Kokudo N, et al. Positive and negative staining of hepatic segments by use of fluorescent imaging techniques during laparoscopic hepatectomy. Arch Surg. 2012;147(4):393–394. doi:10.1001/archsurg.2012.59.
   PubMedGoogle Scholar
• Wang X, Teh CSC, Ishizawa T, et al. Consensus guidelines for the use of fluorescence imaging in hepatobiliary surgery. Ann Surg. 2021;274(1):97–106. doi:10.1097/SLA.0000000000004718.
   PubMed Web of Science ®Google Scholar
• Alfano MS, Molfino S, Benedicenti S, et al. Intraoperative ICG-based imaging of liver neoplasms: a simple yet powerful tool. Preliminary results. Surg Endosc. 2019;33(1):126–134. doi:10.1007/s00464-018-6282-1.
   PubMed Web of Science ®Google Scholar
• Yokoyama N, Otani T, Hashidate H, et al. Real-time detection of hepatic micrometastases from pancreatic cancer by intraoperative fluorescence imaging: preliminary results of a prospective study. Cancer. 2012;118(11):2813–2819. doi:10.1002/cncr.26594.
   PubMed Web of Science ®Google Scholar
• Tummers QR, Verbeek FP, Prevoo HA, et al. First experience on laparoscopic near-infrared fluorescence imaging of hepatic uveal melanoma metastases using indocyanine green. Surg Innov. 2015;22(1):20–25. doi:10.1177/1553350614535857.
   PubMed Web of Science ®Google Scholar
• Kokudo N, Takemura N, Hasegawa K, et al. Clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2017 (4th JSH-HCC guidelines) 2019 update. Hepatol Res. 2019;49(10):1109–1113. doi:10.1111/hepr.13411.
   PubMed Web of Science ®Google Scholar
• Singal AG, Llovet JM, Yarchoan M, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922–1965. doi:10.1097/HEP.0000000000000466.
   PubMed Web of Science ®Google Scholar
• Siriwardena AK, Serrablo A, Fretland AA, et al. Abdominal radiology, C.; interventional radiology society of Europe consensus on colorectal cancer with synchronous liver, m., multisocietal european consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE. Br J Surg. 2023;110(9):1161–1170. doi:10.1093/bjs/znad124.
   Web of Science ®Google Scholar
• Hocquelet A, Aubé C, Rode A, et al. Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC. J Hepatol. 2017;66(1):67–74. doi:10.1016/j.jhep.2016.07.010.
   PubMed Web of Science ®Google Scholar
• Ahn SJ, Lee JM, Lee DH, et al. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2017;66(2):347–354. doi:10.1016/j.jhep.2016.09.003.
   PubMed Web of Science ®Google Scholar
• Xu M, Xu D, Deng Z, et al. Long-term outcomes of endoscopic ultrasound-guided laser ablation for liver tumors in the caudate lobe: 5 years of experience. Scand J Gastroenterol. 2023;58(5):558–564. doi:10.1080/00365521.2022.2148833.
   PubMed Web of Science ®Google Scholar
• Meng YF, Jiang BB, Yan K, et al. Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder. International Journal of Hyperthermia. 2023;40(1):2182748. doi:10.1080/02656736.2023.2182748.
   Web of Science ®Google Scholar
• Fuchs CS, Doi T, Jang RW, et al. Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 trial. JAMA Oncol. 2018;4(5):e180013. doi:10.1001/jamaoncol.2018.0013.
   PubMed Web of Science ®Google Scholar
• Kim N, Cheng J, Jung I, et al. Stereotactic body radiation therapy vs. radiofrequency ablation in asian patients with hepatocellular carcinoma. J Hepatol. 2020;73(1):121–129. doi:10.1016/j.jhep.2020.03.005.
   PubMed Web of Science ®Google Scholar
• Vietti Violi N, Duran R, Guiu B, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3(5):317–325. doi:10.1016/S2468-1253(18)30029-3.
   PubMed Web of Science ®Google Scholar
• Widmann G, Bodner G, Bale R. Tumour ablation: technical aspects. Cancer Imaging. 2009;9 Spec No A(Special issue A):S63–S7. doi:10.1102/1470-7330.2009.9026.
   PubMedGoogle Scholar
• Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158–171. doi:10.1097/01.sla.0000171032.99149.fe.
   PubMed Web of Science ®Google Scholar
• Xu EJ, Lv SM, Li K, et al. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging. Int J Hyperthermia. 2018;34(6):870–876. doi:10.1080/02656736.2017.1373306.
   PubMed Web of Science ®Google Scholar
• Shi L, Wang J, Ding N, et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nat Commun. 2019;10(1):5421. doi:10.1038/s41467-019-13204-3.
   PubMed Web of Science ®Google Scholar
• Markezana A, Goldberg SN, Kumar G, et al. Incomplete thermal ablation of tumors promotes increased tumorigenesis. Int J Hyperthermia. 2021;38(1):263–272. doi:10.1080/02656736.2021.1887942.
   PubMed Web of Science ®Google Scholar
• Lee MW. Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention. Ultrasonography. 2014;33(4):227–239. doi:10.14366/usg.14021.
   PubMedGoogle Scholar
• Zhou J, Fan X, Wu D, et al. Hot-band absorption of indocyanine green for advanced anti-stokes fluorescence bioimaging. Light Sci Appl. 2021;10(1):182. doi:10.1038/s41377-021-00627-1.
   PubMed Web of Science ®Google Scholar
• Ishizawa T, Masuda K, Urano Y, et al. Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma. Ann Surg Oncol. 2014;21(2):440–448. doi:10.1245/s10434-013-3360-4.
   PubMed Web of Science ®Google Scholar
• Chung MH, Wood TF, Tsioulias GJ, et al. Laparoscopic radiofrequency ablation of unresectable hepatic malignancies. A phase 2 trial. Surg Endosc. 2001;15(9):1020–1026. doi:10.1007/s00464-001-0026-2.
   PubMed Web of Science ®Google Scholar
• Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol. 2000;7(8):593–600. doi:10.1007/BF02725339.
   PubMed Web of Science ®Google Scholar
• Meng Y, Jiang B, Yan K, et al. Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder. Int J Hyperthermia. 2023;40(1):2182748.
   PubMed Web of Science ®Google Scholar